Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey-Reference-Cited by-同舟云学术

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey

Published:2020-03-02 Issue:10 Volume:16 Page:2504-2508
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Gönüllü Erdem¹^ORCID,Soysal Ahmet¹,Yıldız Ismail²,Aydemir Gökhan¹,Tunç Turan¹,Karaböcüoğlu Metin¹

Affiliation:

1. Clinic of Pediatrics, Ataşehir Memorial Hospital, Istanbul, Turkey

2. Clinic of Pediatrics, Şişli Memorial Hospital, Istanbul, Turkey

Funder

specific grant from funding agencies in the public, commercial, or not-for-profit sectors

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1727212

Reference25 articles.

1. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011

2. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

4. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population-based study in primary health care

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children;Expert Review of Vaccines;2023-12-20

2. Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India;PLOS ONE;2022-12-15

3. Effect of the Pneumococcal Conjugated Vaccines on Burden of all Cause Pneumonia, Bacterial Pneumonia and Empyema in Children;Mikrobiyoloji Bulteni;2022-07-30

4. Response to “Letter to the Editor: Vaccine Failures in Pediatric Cases Caused by Streptococcus pneumoniae Serotype 19A”;Human Vaccines & Immunotherapeutics;2020-08-04

5. Vaccine failures in pediatric cases caused by streptococcus pneumoniae serotype 19A;Human Vaccines & Immunotherapeutics;2020-07-23